In the last 15 years of my career, I worked as a physician and medical director exclusively in the SNF setting. When the National Partnership to Improve Dementia Care went live in 2012, as a CALTCM board member, I joined the California Partnership to Improve Dementia Care, where I have continued to serve even after retiring from full time practice at the end of 2020. That partnership developed a model informed consent form in 2015 for use in older adults with dementia and psychosis living in SNFs (attached). With the approval of brexipiprazole (Rexulti) in 2023, this form is out of date. A new form is expected in 2025 when CDPH completes its informed consent tool kit for psychotropic medications in SNFs.